Skip to main content
OpenTrials

Clinical trial condition

Advanced Renal Cell Carcinoma (aRCC)

Explore clinical trials studying Advanced Renal Cell Carcinoma (aRCC). Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Advanced Renal Cell Carcinoma (aRCC) trial results

Recruiting

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

NCT07188896

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma (aRCC), Carcinoma, +16 more
Locations
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View Trial Details

Related conditions